Cellectis S.A. (EPA: ALCLS) Stock Analysis & Fundamentals

ALCLSCellectis S.A.

EPA · FR · Healthcare · Biotechnology · cellectis.com

2.872EUR-2.64%Mkt Cap: 314.14M $P/E: —Today

Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and g…

Headline	Source	Time
Yesterday
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading European equities traded in the US as American depositary receipts were tracking higher late Thursda	MMT Newswires	1d
This week
European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading European equities traded in the US as American depositary receipts were trending lower in late Tuesd	MMT Newswires	Aug 18
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading European equities traded in the US as American depositary receipts started the week tracking modestl	MMT Newswires	Aug 17
Older
European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading European equities traded in the US as American depositary receipts were tracking lower late Friday m	MMT Newswires	Aug 14
What's Up New York: Cellectis, société française spécialisée dans la thérapie cellulaire des cancers - 13/12	Orange Actualités	Aug 14
European Equities Traded in the US Rise in Thursday Trading European equities traded in the US as American depositary receipts were higher late Thursday morning	MMT Newswires	Aug 13
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading European equities traded in the US as American depositary receipts were tracking higher late Tuesday	MMT Newswires	Aug 11
European Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading European equities traded in the US as American depositary receipts started the week modestly higher	MMT Newswires	Aug 10
What's Up New York: Cellectis, société française spécialisée dans la thérapie cellulaire des cancers - 13/12	Orange Actualités	Aug 10
Horizon de trésorerie assuré jusqu'en 2027 pour Cellectis	Zonebourse	Aug 7
Horizon de trésorerie assuré jusqu'en 2027 pour Cellectis	Zonebourse Suisse	Aug 7
Horizon de trésorerie assuré jusqu'en 2027 pour Cellectis	boursedirect.fr	Aug 7
Horizon de trésorerie assuré jusqu'en 2027 pour Cellectis	boursedirect.fr	Aug 7
Cellectis : un horizon de financement au 4e trimestre 2027, 39,6 M$ de pertes S1	Boursier.com	Aug 7
Le BPA de Cellectis a dépassé les attentes de 0,04$, le CA en dessous des prévisions	Investing.com France	Aug 7
Cellectis S A : publie ses résultats financiers du deuxième trimestre 2026	Zonebourse	Aug 6
Cellectis S A : publie ses résultats financiers du deuxième trimestre 2026	Zonebourse Suisse	Aug 6
Cellectis publie ses résultats financiers du deuxième trimestre 2026	GlobeNewswire	Aug 6
European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading European equities traded in the US as American depositary receipts were heading higher late Thursday	MMT Newswires	Aug 6
European Equities Traded in the US as American Depositary Receipts Edge Up in Wednesday Trading European equities traded in the US as American depositary receipts were edging higher late Wednesday	MMT Newswires	Aug 5
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading European equities traded in the US as American depositary receipts were tracking higher late Wednesd	MMT Newswires	Jul 22
European Equities Traded in the US as American Depositary Receipts Decline Sharply in Wednesday Trading	MMT Newswires	Jul 8
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading	MMT Newswires	Jul 2
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	MMT Newswires	Jun 30
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading	MMT Newswires	Jun 29
ALCLS Prévisions - Objectif de prix pour 2027	TradingView	Jun 27
European Equities Traded in US as ADRs Rise in Thursday Trading	MMT Newswires	Jun 25
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading	MMT Newswires	Jun 24
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	MMT Newswires	Jun 22
European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading	MMT Newswires	Jun 18
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Tuesday Trading	MMT Newswires	Jun 16
Ferretti Leads The Charge In European Penny Stock Opportunities	Simply Wall St.	Jun 12
Cellectis Says Phase 1 Lasme-cel Study Shows 100% Response Rate in B-Cell Leukemia Patients	MMT Newswires	Jun 11
Cellectis présente les résultats finaux de phase 1 pour lasmé-cel et des résultats préliminaires pou...	Fortuneo	Jun 11
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	MMT Newswires	Jun 10
Cellectis : L'autorité sanitaire américaine envoie un signal réglementaire	BFM Bourse	Jun 10
CLLS Stock Rallies Over 24% After Hours — Here's Why	Stocktwits	Jun 10
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading	MMT Newswires	Jun 9
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	MMT Newswires	Jun 8
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Rise for Week	MMT Newswires	Jun 5
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	MMT Newswires	Jun 4
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading	MMT Newswires	Jun 3
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Flat for Week	MMT Newswires	May 29
Barclays initiates oncology-focused biotechs with positive outlook	Investing.com	May 28
European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday	MMT Newswires	May 28
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	MMT Newswires	May 19
Cellectis présente sa plateforme d'édition épigénétique pour éteindre des gènes sans modifier l'ADN, lors du congrès annuel de l'ASGCT	Boursier.com	Apr 28
Cellectis : 100 % de taux de réponse pour sa thérapie CAR-T contre la leucémie	Idéal Investisseur	Mar 20
Nouvelle feuille de route 2026 pour Cellectis, qui se fixe deux priorités	boursorama.com	Jan 9

Industry Peers